Exhibit 10.2

THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE
DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF A
WRITTEN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY
TO THE COMPANY THAT THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF
MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM
REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS.

NOVARAY MEDICAL, INC.

Series A-1 Senior Secured 10% Convertible Note

Date: March     , 2010

For value received, NOVARAY MEDICAL, INC., a Delaware corporation (the
“Company”), hereby promises to pay to the order of
[                            ] (together with its successors, representatives,
and permitted assigns, the “Holder”), in accordance with the terms hereinafter
provided, the principal amount of [                            ($        )],
together with interest thereon. The Company is issuing this Series A-1 senior
secured 10% convertible note (this “Note”) to the Holder pursuant to the
Purchase Agreement (as defined in Section 1.1 hereof). Any other Series A-1
senior secured 10% convertible notes issued pursuant to the Purchase Agreement
shall hereinafter be referred to as the “Other Notes” and such Holders,
collectively, as the “Other Holders”. This Note and the Other Notes are referred
to as the “Notes.”

All payments under or pursuant to this Note shall be made in United States
Dollars in immediately available funds to the Holder at the address of the
Holder as set forth in the Purchase Agreement or at such other place as the
Holder may designate from time to time in writing to the Company or by wire
transfer of funds to the Holder’s account, instructions for which are attached
hereto as Exhibit A. Unless otherwise converted in accordance with the terms of
this Note, the outstanding principal balance and all accrued Interest (as
defined herein) of this Note shall be due and payable on June 30, 2010 (the
“Maturity Date”) or at such earlier time as provided herein.

This Note is secured by a Security Agreement dated the date hereof (the
“Security Agreement”) of the Company in favor of the Holder covering certain
collateral (the “Collateral”), all as more particularly described and provided
therein, and is entitled to the benefits thereof. The Security Agreement, the
Uniform Commercial Code financing statements in connection with the Security
Agreement and any and all other documents executed and delivered by the Company
to the Holder under which the Holder is granted liens on assets of the Company
are collectively referred to as the “Security Documents.”

 

1

--------------------------------------------------------------------------------

ARTICLE I

Section 1.1 Purchase Agreement. This Note has been executed and delivered
pursuant to the Note and Warrant Purchase Agreement dated as of March 11, 2010
(the “Purchase Agreement”) by and among the Company and the purchasers listed
therein. Capitalized terms used and not otherwise defined herein shall have the
meanings set forth for such terms in the Purchase Agreement.

Section 1.2 Interest. Beginning on the issuance date of this Note (the “Issuance
Date”), the outstanding principal balance of this Note shall bear interest
(“Interest”), at a rate per annum equal to ten percent (10%), so long as any
principal amount evidenced by this Note remains outstanding. Interest shall be
payable in cash on the Maturity Date. Interest shall be computed on the basis of
a 360-day year of twelve (12) 30-day months and shall accrue commencing on the
Issuance Date. Furthermore, upon the occurrence of an Event of Default (as
defined in Section 2.1 hereof), then to the extent permitted by law, the Company
will pay Interest in cash to the Holder, payable on demand, on the outstanding
principal balance of this Note from the date of the Event of Default through the
date of payment at a new rate per annum equal to of the lesser of (i) fifteen
percent (15%) and (ii) the maximum applicable legal rate per annum (the “Default
Rate”).

Section 1.3 Covenants. The Company covenants with the Holder that the Company
shall perform any and all acts and execute any and all documents (including,
without limitation, the execution, amendment or supplementation of any financing
statement and continuation statement) for filing under the provisions of the
Uniform Commercial Code (the “UCC”), and the rules and regulations thereunder,
or any other statute, rule or regulation of any applicable jurisdiction which
are necessary and/or advisable at the request of the Holder or its counsel in
order to maintain in favor of the Holder of this Note, a valid and perfected
lien on the Collateral (as defined in the Security Agreement).

Section 1.4 Payment on Non-Business Days. Whenever any payment to be made shall
be due on a Saturday, Sunday or a public holiday under the laws of the State of
New York, such payment may be due on the next succeeding business day and such
next succeeding day shall be included in the calculation of the amount of
accrued Interest payable on such date.

Section 1.5 Transfer. Except as set forth below, this Note may be transferred or
sold, subject to the provisions of Section 4.8 of this Note, or pledged,
hypothecated or otherwise granted as security by the Holder. This Note may not
be transferred or sold or pledged, hypothecated or otherwise granted as security
by the Holder by operation of law or otherwise to any competitor of the Company,
General Electric Co., Koninklijke Philips Electronics N.V., Siemens AG, Toshiba
Corporation, Baytree Capital Associates, LLC or any of their affiliates without
written consent of the Company.

Section 1.6 Replacement. Upon receipt of a duly executed and notarized written
statement from the Holder with respect to the loss, theft or destruction of this
Note (or any replacement hereof) and a standard indemnity reasonably
satisfactory to the Company, or, in the case of a mutilation of this Note, upon
surrender and cancellation of such Note, the Company

 

2

--------------------------------------------------------------------------------

shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen,
destroyed or mutilated Note.

ARTICLE II

EVENTS OF DEFAULT; REMEDIES

Section 2.1 Events of Default. The occurrence of any of the following events
shall be an “Event of Default” under this Note:

(a) the Company shall fail to make any principal or Interest payments due under
this Note on the date such payments are due and such default is not fully cured
within two (2) business days after the occurrence thereof; or

(b) default shall be made in the performance or observance of any covenant,
condition or agreement contained in this Note or any other Transaction Document,
which default has or would be reasonably expected to have a Material Adverse
Effect, and such default is not fully cured within fifteen (15) business days
after the Holder delivers written notice to the Company of the occurrence
thereof; or

(c) any representation or warranty made by the Company herein or in the Purchase
Agreement, the Other Notes, the Warrants, the Security Documents or any other
Transaction Document shall prove to have been false or incorrect or breached in
a material respect on the date as of which made and such falsehood,
incorrectness or breach has or would reasonably be expected to have a Material
Adverse Effect; or

(d) the Company shall (i) apply for or consent to the appointment of, or the
taking of possession by, a receiver, custodian, trustee or liquidator of itself
or of all or a substantial part of its property or assets, (ii) make a general
assignment for the benefit of its creditors, (iii) commence a voluntary case
under the United States Bankruptcy Code (as now or hereafter in effect) or under
the comparable laws of any jurisdiction (foreign or domestic), (iv) file a
petition seeking to take advantage of any bankruptcy, insolvency, moratorium,
reorganization or other similar law affecting the enforcement of creditors’
rights generally, (v) acquiesce in writing to any petition filed against it in
an involuntary case under United States Bankruptcy Code (as now or hereafter in
effect) or under the comparable laws of any jurisdiction (foreign or domestic),
or (vi) issue a notice of bankruptcy of ceased operations or issue a press
release regarding same; or

(e) a proceeding or case shall be commenced in respect of the Company by a party
other than a Holder or Other Holder, without its application or consent, in any
court of competent jurisdiction, seeking (i) the liquidation, reorganization,
moratorium, dissolution, winding up, or composition or readjustment of its
debts, (ii) the appointment of a trustee, receiver, custodian, liquidator or the
like of it or of all or any substantial part of its assets in connection with
its liquidation or dissolution or (iii) similar relief in respect of it under
any law providing for the relief of debtors, and such proceeding or case
described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed
and in effect, for a period of thirty (30) days or any order for relief shall be
entered in an involuntary case under United States Bankruptcy Code (as now or

 

3

--------------------------------------------------------------------------------

hereafter in effect) or under the comparable laws of any jurisdiction (foreign
or domestic) against the Company or action under the laws of any jurisdiction
(foreign or domestic) analogous to any of the foregoing shall be taken with
respect to the Company and shall continue undismissed, or unstayed and in effect
for a period of thirty (30) days; or

(f) the occurrence of a material event of default under any other Transaction
Document not otherwise provided for in Section 2.1(a), (b), (c), (d) or
(e) hereof, which event of default has or would reasonably be expected to have a
Material Adverse Effect.

Section 2.2 Remedies Upon An Event of Default. If an Event of Default shall have
occurred and shall be continuing, the Holder of this Note may at any time at its
option, (a) declare the entire unpaid principal balance of this Note, together
with all Interest accrued hereon, due and payable, and thereupon, the same shall
be accelerated and so due and payable, without presentment, demand, protest, or
notice, all of which are hereby expressly unconditionally and irrevocably waived
by the Company; provided, however, that upon the occurrence of an Event of
Default described in Sections 2.1(c) or (d), the outstanding principal balance
and accrued Interest hereunder shall be automatically due and payable, or
(b) exercise or otherwise enforce any one or more of the Holder’s rights,
powers, privileges, remedies and interests under this Note, the Purchase
Agreement, the Security Documents or applicable law. No course of delay on the
part of the Holder shall operate as a waiver thereof or otherwise prejudice the
right of the Holder. No remedy conferred hereby shall be exclusive of any other
remedy referred to herein or now or hereafter available at law, in equity, by
statute or otherwise.

ARTICLE III

CONVERSION

Section 3.1 Mandatory Conversion. Effective as of the closing (the “Mandatory
Conversion Date”) of a Qualified Financing (as defined below), any and all
outstanding principal and accrued Interest represented by this Note shall
automatically (without further act or deed of the Holder or the Company) convert
(the “Mandatory Conversion”) into the same type or package of securities of the
Company issued or issuable by the Company in the Qualified Financing (the
“Qualified Financing Stock”) as if the Holder was investing new capital into
such Qualified Financing. A “Qualified Financing” shall occur when a sale by the
Company of shares of equity of the Company to one or more purchasers generates
not less than gross proceeds to the Company of $5,000,000 (exclusive of amounts
paid for cancellation or conversion of the Notes) prior to the Maturity Date in
a transaction or series of related transactions as part of multiple closings
under materially similar set of terms. Qualified Financing Stock shall include
subsequent issuances of equity issued pursuant to definitive agreements for such
Qualified Financing. The Company shall cause notice of the Mandatory Conversion
(the “Mandatory Conversion Notice”) to be mailed to the Holder, at such Holder’s
address, at least ten (10) days prior to the Mandatory Conversion Date. On or
within three (3) business days after the Mandatory Conversion Date, the Holder
shall surrender this Note at the place designated in such notice, together with
a statement of the name or names (with address) in which the certificate or
certificates for shares of Qualified Financing Stock which shall be issuable on
such conversion shall be issued.

 

4

--------------------------------------------------------------------------------

Section 3.2 Mechanics of Conversion. Not later than ten (10) Trading Days after
the Mandatory Conversion Date (the “Delivery Date”), the Company or its
designated transfer agent, as applicable, shall issue and deliver to the Holder
the Conversion Securities as specified in the Mandatory Conversion Notice.
Notwithstanding the foregoing, in the alternative, not later than the Delivery
Date, the Company shall deliver to the Holder by express courier a certificate
or certificates which shall be free of restrictive legends and trading
restrictions (other than those required by Section 5.1 of the Purchase Agreement
and/or the related documentation of the Qualified Financing) representing the
number of Conversion Securities being acquired upon the conversion of this Note.

Section 3.3 No Impairment. The Company shall not, by amendment of its
Certificate of Incorporation or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed hereunder by the Company, but will at all
times in good faith, assist in the carrying out of all the provisions of this
Note and in the taking of all such action as may be necessary or appropriate in
order to protect the conversion rights of the Holder against impairment. In the
event the Holder shall elect to convert this Note as provided herein, the
Company cannot refuse conversion based on any claim that the Holder or any one
associated or affiliated with the Holder has been engaged in any violation of
law, violation of an agreement to which the Holder is a party or for any reason
whatsoever, unless, an injunction from a court, or notice, restraining and or
adjoining conversion of all or a portion of this Note shall have issued and the
Company posts a surety bond for the benefit of the Holder in an amount equal to
one hundred percent (100%) of the amount of this Note the Holder has elected to
convert, which bond shall remain in effect until the completion of
arbitration/litigation of the dispute and the proceeds of which shall be payable
to the Holder (as liquidated damages) in the event it obtains judgment.

Section 3.4 Issue Taxes. The Company shall pay any and all issue and other
taxes, excluding federal, state or local income taxes, that may be payable in
respect of any issue or delivery of securities on conversion of this Note
pursuant thereto; provided, however, that the Company shall not be obligated to
pay any transfer taxes resulting from any transfer requested by the Holder in
connection with any such conversion.

Section 3.5 Fractional Shares. No fractional shares of Conversion Securities
shall be issued upon conversion of this Note, but in lieu of such fractional
shares, the Company shall round the number of shares of Conversion Securities to
be issued upon conversion down to the nearest whole number of shares.

Section 3.6 No Rights as Stockholder. Nothing contained in this Note shall be
construed as conferring upon the Holder, prior to the conversion of this Note,
the right to vote or to receive dividends or to consent or to receive notice as
a stockholder in respect of any meeting of stockholders for the election of
directors of the Company or of any other matter, or any other rights as a
stockholder of the Company.

 

5

--------------------------------------------------------------------------------

ARTICLE IV

MISCELLANEOUS

Section 4.1 Notices. Any notice, demand, request, waiver or other communication
required or permitted to be given hereunder shall be in writing and shall be
effective (a) upon hand delivery or facsimile at the address or number
designated in the Purchase Agreement (if delivered on a business day during
normal business hours where such notice is to be received), or the first
business day following such delivery (if delivered other than on a business day
during normal business hours where such notice is to be received) or (b) on the
second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such
mailing, whichever shall first occur. The Company will give written notice to
the Holder at least ten (10) days prior to the date on which the Company takes a
record (x) with respect to any dividend or distribution upon the Common Stock,
(y) with respect to any pro rata subscription offer to holders of Common Stock
or (z) for determining rights to vote with respect to any Organic Change,
dissolution, liquidation or winding-up but in no event shall such notice be
provided to the Holder prior to such information being made known to the public.
The Company will also give written notice to the Holder at least ten (10) days
prior to the date on which any Organic Change, dissolution, liquidation or
winding-up will take place but in no event shall such notice be provided to the
Holder prior to such information being made known to the public. The Company
shall promptly notify the Holder of any notices sent or received, or any actions
taken with respect to the Other Notes.

Section 4.2 Governing Law; Consent to Jurisdiction. The parties acknowledge and
agree that any claim, controversy, dispute or action relating in any way to this
agreement or the subject matter of this agreement shall be governed solely by
the laws of the State of New York, without regard to any conflict of laws
doctrines. The parties irrevocably consent to being served with legal process
issued from the state and federal courts located in New York and irrevocably
consent to the exclusive personal jurisdiction of the federal and state courts
situated in the State of New York. The parties irrevocably waive any objections
to the personal jurisdiction of these courts. Said courts shall have sole and
exclusive jurisdiction over any and all claims, controversies, disputes and
actions which in any way relate to this agreement or the subject matter of this
agreement. The parties also irrevocably waive any objections that these courts
constitute an oppressive, unfair, or inconvenient forum and agree not to seek to
change venue on these grounds or any other grounds. Nothing in this Section 4.2
shall affect or limit any right to serve process in any other manner permitted
by law.

Section 4.3 Headings. Article and section headings in this Note are included
herein for purposes of convenience of reference only and shall not constitute a
part of this Note for any other purpose.

Section 4.4 Remedies, Characterizations, Other Obligations, Breaches and
Injunctive Relief. The remedies provided in this Note shall be cumulative and in
addition to all other remedies available under this Note, at law or in equity
(including, without limitation, a decree of specific performance and/or other
injunctive relief), no remedy contained herein shall be deemed a waiver of
compliance with the provisions giving rise to such remedy and nothing

 

6

--------------------------------------------------------------------------------

herein shall limit a Holder’s right to pursue actual damages for any failure by
the Company to comply with the terms of this Note. Amounts set forth or provided
for herein with respect to payments, conversion and the like (and the
computation thereof) shall be the amounts to be received by the Holder hereof
and shall not, except as expressly provided herein, be subject to any other
obligation of the Company (or the performance thereof). The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable and
material harm to the Holder and that the remedy at law for any such breach may
be inadequate. Therefore the Company agrees that, in the event of any such
breach or threatened breach, the Holder shall be entitled, in addition to all
other available rights and remedies, at law or in equity, to seek and obtain
such equitable relief, including but not limited to an injunction restraining
any such breach or threatened breach, without the necessity of showing economic
loss and without any bond or other security being required.

Section 4.5 Enforcement Expenses. The Company agrees to pay all costs and
expenses of the Holder incurred as a result of enforcement of this Note,
including, without limitation, reasonable attorneys’ fees and expenses.

Section 4.6 Binding Effect. The obligations of the Company and the Holder set
forth herein shall be binding upon the successors and assigns of each such
party, whether or not such successors or assigns are permitted by the terms
hereof.

Section 4.7 Amendments. This Note may be amended and any provision herein
modified with the consent of the Company and Holders of more than fifty percent
(50%) of the aggregate outstanding principal balance of the Notes.

Section 4.8 Compliance with Securities Laws. The Holder of this Note
acknowledges that this Note is being acquired solely for the Holder’s own
account and not as a nominee for any other party, and for investment, and that
the Holder shall not offer, sell or otherwise dispose of this Note. This Note
and any Note issued in substitution or replacement therefor shall be stamped or
imprinted with a legend in substantially the following form:

“THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE
DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF A
WRITTEN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY
TO THE COMPANY THAT THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF
MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM
REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS.”

 

7

--------------------------------------------------------------------------------

Section 4.9 Accredited Investor Status. In no event may the Holder convert this
Note in whole or in part unless the Holder is an “accredited investor” as
defined in Regulation D under the Act.

Section 4.10 Parties in Interest. This Note shall be binding upon, inure to the
benefit of and be enforceable by the Company, the Holder and their respective
successors and permitted assigns.

Section 4.11 Failure or Indulgence Not Waiver. No failure or delay on the part
of the Holder in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any
such power, right or privilege preclude other or further exercise thereof or of
any other right, power or privilege, nor shall any waiver by the Holder of any
such right or rights on any one occasion be deemed a waiver of the same right or
rights on any future occasion.

Section 4.12 Company’s Waivers.

(a) Except as otherwise specifically provided herein, the Company and all others
that may become liable for all or any part of the obligations evidenced by this
Note, hereby waive presentment, demand, notice of nonpayment, protest and all
other demands’ and notices in connection with the delivery, acceptance,
performance and enforcement of this Note, and do hereby consent to any number of
renewals of extensions of the time or payment hereof and agree that any such
renewals or extensions may be made without notice to any such persons and
without affecting their liability herein and do further consent to the release
of any person liable hereon, all without affecting the liability of the other
persons, firms or the Company liable for the payment of this Note, AND DO HEREBY
WAIVE TRIAL BY JURY.

(b) THE COMPANY ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART
IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY
WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY
WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.

Section 4.13 Definitions. For the purposes hereof, the following terms shall
have the following meanings:

“business days” has the meaning given such term in the Security Agreement.

“Conversion Securities” means Qualified Financing Stock issuable upon a
Mandatory Conversion of this Note in connection with the occurrence of a
Qualified Financing.

“Organic Change” means a capital reorganization of the Company (other than by
way of a stock split or combination of shares, or stock dividends or
distributions on the Common Stock, or a reclassification, exchange or
substitution of the Common Stock not otherwise covered by the further provisions
of this definition), or a merger or consolidation of the Company with or into
another corporation where the holders of outstanding voting securities of the
Company prior to such merger or consolidation do not own over fifty percent
(50%) of the

 

8

--------------------------------------------------------------------------------

outstanding voting securities of the merged or consolidated entity, immediately
after such merger or consolidation, or the sale of all or substantially all of
the Company’s properties or assets to any other person.

“Trading Day” means (a) a day on which the Common Stock is traded on the OTC
Bulletin Board, or (b) if the Common Stock is not traded on the OTC Bulletin
Board, a day on which the Common Stock is quoted in the over-the-counter market
as reported by the National Quotation Bureau Incorporated (or any similar
organization or agency succeeding its functions of reporting prices); provided,
however, that in the event that the Common Stock is not listed or quoted as set
forth in (a) or (b) hereof, then Trading Day shall mean any day except Saturday,
Sunday and any day which shall be a legal holiday or a day on which banking
institutions in the State of New York are authorized or required by law or other
government action to close.

[remainder of page intentionally left blank]

 

9

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed as of
the date set out above.

 

NOVARAY MEDICAL, INC. By:  

 

Name:   Title:  

 

10